Philip Morris International's Vectura Fertin Pharma has announced the sale of its asthma inhaler maker Vectura Group to Molex Asia Holdings for 150 million pounds. PMI acquired Vectura in 2021 as part of its healthcare transformation plan but faced criticism. The deal includes potential deferred payments of up to 148 million pounds. Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
